Q2 2025 Holdings
Filed 2025-08-14 | 33 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $323.7M | 3,507,164 | 29.5% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $166.0M | 7,707,165 | 15.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $106.2M | 2,887,933 | 9.7% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $91.3M | 76,075,636 | 8.3% |
| Illumina Inc(ILMN) | COM | 452327109 | $61.5M | 645,000 | 5.6% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $50.4M | 1,775,000 | 4.6% |
| Verve Therapeutics Inc | COM | 92539P101 | $46.0M | 4,095,571 | 4.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $39.4M | 11,398,574 | 3.6% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $26.6M | 81,500 | 2.4% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $25.4M | 1,225,000 | 2.3% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $24.7M | 1,450,000 | 2.2% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $19.4M | 1,295,361 | 1.8% |
| Codexis Inc(CDXS) | COM | 192005106 | $17.6M | 7,200,000 | 1.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $16.9M | 990,097 | 1.5% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $12.5M | 890,000 | 1.1% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $11.5M | 230,000 | 1.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $9.3M | 758,857 | 0.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $7.5M | 276,308 | 0.7% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $6.6M | 8,500 | 0.6% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $6.1M | 650,000 | 0.6% |
| Septerna Inc(SEPN) | COM | 81734D104 | $5.8M | 553,268 | 0.5% |
| Guardant Health Inc(GH) | COM | 40131M109 | $5.2M | 100,000 | 0.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $4.8M | 90,000 | 0.4% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $3.9M | 1,567,175 | 0.4% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $3.3M | 100,000 | 0.3% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.5M | 973,260 | 0.2% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $897.5K | 723,767 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $836.5K | 165,323 | 0.1% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $686.2K | 1,228,190 | 0.1% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $588.9K | 148,333 | 0.1% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $410.5K | 36,493 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $387.9K | 86,014 | 0.0% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $221.2K | 361,969 | 0.0% |